News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
197,992 Results
Type
Article (9407)
Company Profile (39)
Press Release (188546)
Multimedia
Podcasts (7)
Webinars (4)
Section
Business (64950)
Career Advice (273)
Deals (12575)
Drug Delivery (23)
Drug Development (24794)
Employer Resources (69)
FDA (4632)
Job Trends (5209)
News (105113)
Policy (7886)
Tag
Academia (655)
Accelerated approval (1)
Adcomms (3)
Allergies (41)
Alliances (9493)
ALS (25)
Alzheimer's disease (445)
Antibody-drug conjugate (ADC) (44)
Approvals (4689)
Artificial intelligence (58)
Autoimmune disease (7)
Automation (3)
Bankruptcy (78)
Best Places to Work (4432)
BIOSECURE Act (2)
Biosimilars (32)
Biotechnology (25)
Bladder cancer (36)
Brain cancer (17)
Breast cancer (137)
Cancer (1085)
Cardiovascular disease (89)
Career advice (225)
Career pathing (6)
CAR-T (42)
CDC (11)
Cell therapy (132)
Cervical cancer (5)
Clinical research (21373)
Collaboration (220)
Company closure (1)
Compensation (500)
Complete response letters (2)
COVID-19 (796)
CRISPR (14)
C-suite (127)
Cystic fibrosis (39)
Data (1263)
Denatured (1)
Depression (15)
Diabetes (115)
Diagnostics (1984)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (16)
Drug discovery (36)
Drug pricing (30)
Drug shortages (8)
Duchenne muscular dystrophy (43)
Earnings (40629)
Editorial (9)
Employer branding (6)
Employer resources (57)
Events (28695)
Executive appointments (281)
FDA (5180)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (272)
Gene editing (31)
Generative AI (5)
Gene therapy (108)
GLP-1 (284)
Government (1137)
Grass and pollen (1)
Guidances (156)
Healthcare (6342)
HIV (16)
Huntington's disease (4)
IgA nephropathy (22)
Immunology and inflammation (44)
Immuno-oncology (6)
Indications (16)
Infectious disease (844)
Inflammatory bowel disease (52)
Inflation Reduction Act (3)
Influenza (16)
Intellectual property (28)
Interviews (41)
IPO (7819)
IRA (5)
Job creations (969)
Job search strategy (203)
Kidney cancer (8)
Labor market (21)
Layoffs (162)
Leadership (2)
Legal (1501)
Liver cancer (20)
Longevity (1)
Lung cancer (168)
Lymphoma (94)
Machine learning (1)
Management (23)
Manufacturing (75)
MASH (27)
Medical device (4368)
Medtech (4368)
Mergers & acquisitions (5043)
Metabolic disorders (291)
Multiple sclerosis (37)
NASH (6)
Neurodegenerative disease (34)
Neuropsychiatric disorders (11)
Neuroscience (636)
NextGen: Class of 2025 (1685)
Non-profit (1249)
Now hiring (4)
Obesity (155)
Opinion (49)
Ovarian cancer (32)
Pain (23)
Pancreatic cancer (43)
Parkinson's disease (57)
Partnered (3)
Patents (65)
Patient recruitment (37)
Peanut (22)
People (14380)
Pharmaceutical (11)
Pharmacy benefit managers (2)
Phase I (5694)
Phase II (9263)
Phase III (8322)
Pipeline (983)
Policy (31)
Postmarket research (796)
Preclinical (1847)
Press Release (9)
Prostate cancer (43)
Psychedelics (6)
Radiopharmaceuticals (87)
Rare diseases (158)
Real estate (1287)
Recruiting (29)
Regulatory (5974)
Reports (21)
Research institute (648)
Resumes & cover letters (49)
Rett syndrome (4)
RNA editing (4)
RSV (11)
Schizophrenia (26)
Series A (36)
Series B (21)
Service/supplier (3)
Sickle cell disease (22)
Special edition (7)
Spinal muscular atrophy (74)
Sponsored (10)
Startups (849)
Stomach cancer (4)
Supply chain (16)
Tariffs (16)
The Weekly (6)
Vaccines (273)
Venture capital (12)
Weight loss (97)
Women's health (7)
Worklife (4)
Date
Today (15)
Last 7 days (97)
Last 30 days (695)
Last 365 days (11200)
2025 (6214)
2024 (11742)
2023 (13116)
2022 (30246)
2021 (17359)
2020 (15477)
2019 (13181)
2018 (10058)
2017 (9135)
2016 (8061)
2015 (9863)
2014 (6841)
2013 (5295)
2012 (5455)
2011 (5872)
2010 (4981)
Location
Africa (181)
Alabama (41)
Alaska (1)
Arizona (50)
Arkansas (4)
Asia (11444)
Australia (1814)
California (2649)
Canada (867)
China (214)
Colorado (89)
Connecticut (97)
Delaware (94)
Europe (26760)
Florida (348)
Georgia (72)
Idaho (12)
Illinois (162)
India (11)
Indiana (172)
Iowa (3)
Japan (76)
Kansas (34)
Kentucky (6)
Louisiana (6)
Maine (24)
Maryland (345)
Massachusetts (1852)
Michigan (78)
Minnesota (108)
Mississippi (1)
Missouri (23)
Montana (10)
Nebraska (7)
Nevada (21)
New Hampshire (25)
New Jersey (773)
New Mexico (3)
New York (687)
North Carolina (354)
North Dakota (1)
Northern California (1249)
Ohio (42)
Oklahoma (2)
Oregon (3)
Pennsylvania (607)
Puerto Rico (3)
South America (289)
South Carolina (8)
Southern California (1043)
Tennessee (49)
Texas (401)
United States (9384)
Utah (70)
Virginia (56)
Washington D.C. (12)
Washington State (209)
West Virginia (2)
Wisconsin (14)
197,992 Results for "25".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
INOVIO Announces Pricing of $25 Million Public Offering
July 4, 2025
·
5 min read
Editorial
The Decadent Show of Data at ASCO25
The cancer conference overwhelms the senses and shows off the might of the pharmaceutical industry.
June 3, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Adagene announces up to $25 million strategic investment from Sanofi
July 2, 2025
·
5 min read
Infectious disease
Gilead, GSK/ViiV, Merck Present New HIV PrEP Frontiers at IAS25
HIV pharma leaders are in Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the heels of the landmark Yeztugo approval.
July 15, 2025
·
4 min read
·
Tristan Manalac
Pipeline
JPM25 Day Two: Roche, Amgen, Merck, Lilly and Biogen
JPM25 is in full swing as several pharma powerhouses—including Merck, Lilly and Amgen—detail their strategies for growth in the coming year.
January 15, 2025
·
4 min read
·
Tristan Manalac
Press Releases
Cannara Biotech to Host Investor Webcast on June 25th, 2025
June 19, 2025
·
1 min read
Press Releases
FibroBiologics Closes Third $5 Million Tranche of $25 Million Financing
June 17, 2025
·
4 min read
Press Releases
InVitria Launches Optibumin® 25, the First Recombinant 25% Human Serum Albumin for Closed-System Biomanufacturing
April 30, 2025
·
1 min read
Press Releases
Stonegate Updates Coverage on Burcon Nutrascience Corporation (BU) FY25 Q4
June 26, 2025
·
1 min read
Press Releases
Alzheimer’s Disease Diagnostics Market Size to Reach USD 25.53 Billion by 2034
June 30, 2025
·
1 min read
1 of 19,800
Next
